Melvin Lobo
Latest contributions
Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.
A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort
18 May 2021 – From EuroPCR 2021
Watch this session presented by Ajay Kirtane, Melvin David Lobo and Felix Mahfoud in order to review a history of the field and the recent clinical advancements in renal denervation with the Paradise Ultrasound RDN system, to further examine the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered...
The year in intervention: essential publications from the EuroIntervention Journal and the European Heart Journal
23 May 2019 – From EuroPCR 2019
Consult this session to discover the essential papers from the EuroIntervention Journal and the European Heart Journal in 2019, regarding hypertension, coronary interventions, and more!
Interventions for hypertension beyond the renal artery: a case-based discussion
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about non-renal interventions for hypertension and the different device features, procedural steps and patient selection.
